Alice A. Larson - Publications

Affiliations: 
University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Pain

107 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Goudie-DeAngelis EM, Abdelhamid RE, Nunez MG, Kissel CL, Kovács KJ, Portoghese PS, Larson AA. Modulation of Musculoskeletal Hyperalgesia by Brown Adipose Tissue Activity in Mice. Pain. PMID 27437788 DOI: 10.1097/J.Pain.0000000000000677  0.304
2015 Larson AA, Nunez MG, Kissel CL, Kovács KJ. Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia. The European Journal of Neuroscience. PMID 26332847 DOI: 10.1111/ejn.13060  0.399
2014 Abdelhamid RE, Kovács KJ, Nunez MG, Larson AA. Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 79: 21-7. PMID 24200896 DOI: 10.1016/j.phrs.2013.10.006  0.347
2013 Abdelhamid RE, Kovács KJ, Honda CN, Nunez MG, Larson AA. Resiniferatoxin (RTX) causes a uniquely protracted musculoskeletal hyperalgesia in mice by activation of TRPV1 receptors. The Journal of Pain : Official Journal of the American Pain Society. 14: 1629-41. PMID 24188863 DOI: 10.1016/J.Jpain.2013.07.021  0.361
2013 Abdelhamid RE, Kovacs KJ, Pasley JD, Nunez MG, Larson AA. Forced swim-induced musculoskeletal hyperalgesia is mediated by CRF2 receptors but not by TRPV1 receptors. Neuropharmacology. 72: 29-37. PMID 23624287 DOI: 10.1016/j.neuropharm.2013.04.016  0.323
2005 Taiwo OB, Kovács KJ, Larson AA. Chronic daily intrathecal injections of a large volume of fluid increase mast cells in the thalamus of mice. Brain Research. 1056: 76-84. PMID 16098954 DOI: 10.1016/j.brainres.2005.07.022  0.302
2004 Kehl LJ, Kovács KJ, Larson AA. Tolerance develops to the effect of lipopolysaccharides on movement-evoked hyperalgesia when administered chronically by a systemic but not an intrathecal route. Pain. 111: 104-15. PMID 15327814 DOI: 10.1016/j.pain.2004.06.014  0.301
2004 Taiwo OB, Kovács KJ, Sperry LC, Larson AA. Naloxone-induced morphine withdrawal increases the number and degranulation of mast cells in the thalamus of the mouse. Neuropharmacology. 46: 824-35. PMID 15033342 DOI: 10.1016/j.neuropharm.2003.11.022  0.33
2003 Fang M, Kovács KJ, Fisher LL, Larson AA. Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin. The Journal of Physiology. 549: 903-17. PMID 12717003 DOI: 10.1113/jphysiol.2002.036384  0.412
2003 Tien D, Ohara PT, Larson AA, Jasmin L. Vagal afferents are necessary for the establishment but not the maintenance of kainic acid-induced hyperalgesia in mice. Pain. 102: 39-49. PMID 12620595 DOI: 10.1016/s0304-3959(02)00336-6  0.428
2002 Velázquez RA, McCarson KE, Cai Y, Kovács KJ, Shi Q, Evensjö M, Larson AA. Upregulation of neurokinin-1 receptor expression in rat spinal cord by an N-terminal metabolite of substance P. The European Journal of Neuroscience. 16: 229-41. PMID 12169105 DOI: 10.1046/j.1460-9568.2002.02064.x  0.409
2001 Kovacs KJ, Cai Y, Larson AA. Neuronal nitric oxide synthase (nNOS) mRNA is down-regulated, and constitutive NOS enzymatic activity decreased, in thoracic dorsal root ganglia and spinal cord of the rat by a substance P N-terminal metabolite. The European Journal of Neuroscience. 14: 577-84. PMID 11556883 DOI: 10.1046/j.0953-816X.2001.01675.x  0.42
2000 Larson AA, Kovács KJ, Spartz AK. Intrathecal Zn2+ attenuates morphine antinociception and the development of acute tolerance. European Journal of Pharmacology. 407: 267-72. PMID 11068022 DOI: 10.1016/S0014-2999(00)00715-9  0.383
2000 Larson AA, Giovengo SL, Russell IJ, Michalek JE. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain. 87: 201-11. PMID 10924813 DOI: 10.1016/S0304-3959(00)00284-0  0.34
2000 Larson AA, Giovengo SL, Shi Q, Velázquez RA, Kovacs KJ. Zinc in the extracellular area of the central nervous system is necessary for the development of kainic acid-induced persistent hyperalgesia in mice. Pain. 86: 177-84. PMID 10779674 DOI: 10.1016/S0304-3959(00)00244-X  0.433
2000 Larson AA, Kovacs KJ, Cooper JC, Kitto KF. Transient changes in the synthesis of nitric oxide result in long-term as well as short-term changes in acetic acid-induced writhing in mice. Pain. 86: 103-11. PMID 10779667 DOI: 10.1016/S0304-3959(00)00236-0  0.357
1999 Giovengo SL, Kitto KF, Kurtz HJ, Velázquez RA, Larson AA. Parenterally administered kainic acid induces a persistent hyperalgesia in the mouse and rat. Pain. 83: 347-58. PMID 10534608 DOI: 10.1016/S0304-3959(99)00118-9  0.475
1999 Velázquez RA, Cai Y, Shi Q, Larson AA. The distribution of zinc selenite and expression of metallothionein-III mRNA in the spinal cord and dorsal root ganglia of the rat suggest a role for zinc in sensory transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2288-300. PMID 10066279 DOI: 10.1523/Jneurosci.19-06-02288.1999  0.338
1998 Kovács KJ, Larson AA. Up-regulation of [3H]DTG but not [3H](+)-pentazocine labeled sigma sites in mouse spinal cord by chronic morphine treatment. European Journal of Pharmacology. 350: 47-52. PMID 9683013 DOI: 10.1016/S0014-2999(98)00220-9  0.347
1998 Goettl VM, Larson AA. An antagonist of substance P N-terminal fragments, D-substance P(1-7), reveals that both nociceptive and antinociceptive effects are induced by substance P N-terminal activity during noxious chemical stimulation. Brain Research. 780: 80-5. PMID 9473599 DOI: 10.1016/S0006-8993(97)01146-3  0.413
1998 Budai D, Larson AA. The involvement of metabotropic glutamate receptors in sensory transmission in dorsal horn of the rat spinal cord. Neuroscience. 83: 571-80. PMID 9460763 DOI: 10.1016/S0306-4522(97)00390-4  0.424
1997 Goettl VM, Larson DL, Portoghese PS, Larson AA. Inhibition of substance P release from spinal cord tissue after pretreatment with capsaicin does not mediate the antinociceptive effect of capsaicin in adult mice. Pain. 71: 271-8. PMID 9231870 DOI: 10.1016/S0304-3959(97)03376-9  0.409
1997 Velázquez RA, Kitto KF, Larson AA. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse. The Journal of Pharmacology and Experimental Therapeutics. 281: 1231-7. PMID 9190858  0.347
1997 Kovács KJ, Larson AA. Zn2+ inhibition of [3H]MK-801 binding is different in mouse brain and spinal cord: effect of glycine and glutamate. European Journal of Pharmacology. 324: 117-23. PMID 9137921 DOI: 10.1016/S0014-2999(97)00060-5  0.419
1996 Budai D, Larson AA. Role of substance P in the modulation of C-fiber-evoked responses of spinal dorsal horn neurons. Brain Research. 710: 197-203. PMID 8963659 DOI: 10.1016/0006-8993(95)01384-9  0.354
1996 Goettl VM, Larson AA. Nitric oxide mediates long-term hyperalgesic and antinociceptive effects of the N-terminus of substance P in the formalin assay in mice. Pain. 67: 435-41. PMID 8951939 DOI: 10.1016/0304-3959(96)03155-7  0.403
1996 Kreeger JS, Larson AA. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice. The Journal of Pharmacology and Experimental Therapeutics. 279: 662-7. PMID 8930169  0.301
1996 Hornfeldt CS, Kitto KF, Larson AA. Evidence that the NH2-terminus of substance P modulates N-methyl-D-aspartate-induced activity by an action involving sigma receptors. European Journal of Pharmacology. 306: 15-22. PMID 8813610 DOI: 10.1016/0014-2999(96)00199-9  0.408
1995 Kovács KJ, Larson AA. Discrepancies in characterization of sigma sites in the mouse central nervous system. European Journal of Pharmacology. 285: 127-34. PMID 8566130 DOI: 10.1016/0014-2999(95)00383-V  0.325
1995 Kreeger JS, Yukhananov RYu, Larson AA. Altered N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine is mediated by sigma activity. Brain Research. 672: 83-8. PMID 7749756 DOI: 10.1016/0006-8993(94)01383-S  0.449
1995 Budai D, Wilcox GL, Larson AA. Effects of nitric oxide availability on responses of spinal wide dynamic range neurons to excitatory amino acids. European Journal of Pharmacology. 278: 39-47. PMID 7545123 DOI: 10.1016/0014-2999(95)00100-Y  0.409
1994 Yukhananov RYu, Larson AA. Morphine modulates excitatory amino acid-induced activity in the mouse spinal cord: short-term effects on N-methyl-D-aspartate (NMDA) and long-term effects on kainic acid. Brain Research. 646: 194-200. PMID 8069663 DOI: 10.1016/0006-8993(94)90077-9  0.444
1994 Budai D, Larson AA. GYKI 52466 inhibits AMPA/kainate and peripheral mechanical sensory activity. Neuroreport. 5: 881-4. PMID 8061287 DOI: 10.1097/00001756-199404000-00007  0.435
1994 Goettl VM, Larson AA. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX. Brain Research. 642: 334-8. PMID 8032897 DOI: 10.1016/0006-8993(94)90939-3  0.435
1994 Yukhananov RYu, Larson AA. Involvement of NMDA receptors in naloxone-induced contractions of the isolated guinea pig ileum after preincubation with morphine. The Journal of Pharmacology and Experimental Therapeutics. 271: 1365-70. PMID 7996448  0.301
1994 Kovács KJ, Larson AA. Density of NMDA-coupled and uncoupled 1-[1-(2-[3H]thienyl) cyclohexyl]piperidine recognition sites in the brain and spinal cord: differential effects of NMDA agonists and antagonists. Journal of Neurochemistry. 63: 1757-65. PMID 7931331 DOI: 10.1046/J.1471-4159.1994.63051757.X  0.36
1994 Kreeger JS, Yukhananov RYu, Larson AA. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal. Brain Research. 663: 101-6. PMID 7850459 DOI: 10.1016/0006-8993(94)90467-7  0.433
1994 Mousseau DD, Larson AA. Substance P analogs displace sigma binding differentially in the brain and spinal cord of the adult mouse. Metabolic Brain Disease. 9: 249-55. PMID 7530803 DOI: 10.1007/BF01991198  0.373
1994 Yukhananov RYu, Larson AA. An N-terminal fragment of substance P, substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord. Neuroscience Letters. 178: 163-6. PMID 7529387 DOI: 10.1016/0304-3940(94)90315-8  0.374
1994 Kreeger JS, Kitto KF, Larson AA. Substance P N-terminal metabolites and nitric oxide mediate capsaicin-induced antinociception in the adult mouse. The Journal of Pharmacology and Experimental Therapeutics. 271: 1281-5. PMID 7527854  0.352
1994 Goettl VM, Xu XJ, Larson AA, Wiesenfeld-Hallin Z. Substance P N-terminus inhibits C-fiber-dependent facilitation of the rat flexor reflex. European Journal of Pharmacology. 259: 83-6. PMID 7525313 DOI: 10.1016/0014-2999(94)90162-7  0.347
1994 Goettl VM, Larson AA. Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain. Neuroscience. 60: 375-82. PMID 7521022 DOI: 10.1016/0306-4522(94)90251-8  0.426
1994 Hornfeldt CS, Sun X, Larson AA. The NH2-terminus of substance P modulates NMDA-induced activity in the mouse spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 3364-9. PMID 7514216 DOI: 10.1523/Jneurosci.14-05-03364.1994  0.441
1994 Kreeger JS, Larson AA. Substance P (SP) N-terminal metabolites modulate withdrawal behavior in morphine-dependent mice Regulatory Peptides. 53: S213-S214. DOI: 10.1016/0167-0115(94)90316-6  0.391
1994 Goettl VG, Larson AA. Phencyclidine (PCP) receptors mediate substance P N-terminus-induced hyperalgesia while mu-type opioid receptors mediate its antinociceptive effect Regulatory Peptides. 53: S115-S116. DOI: 10.1016/0167-0115(94)90268-2  0.43
1993 Sun X, Larson AA. MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioral sensitization to kainate. Neuroscience. 54: 773-9. PMID 8101361 DOI: 10.1016/0306-4522(93)90246-C  0.429
1993 Larson AA, Sun X. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity. Neuropharmacology. 32: 909-17. PMID 7694172 DOI: 10.1016/0028-3908(93)90147-U  0.43
1993 Sun X, Larson AA. MK-801 inhibits the effects of capsaicin in the adult mouse by an action involving phencyclidine (PCP) sites not linked to NMDA activity. Neuroreport. 4: 1147-50. PMID 7693010  0.328
1993 Larson AA, Sun X. The amino-terminus of substance P mimics and MK-801 attenuates the effects of capsaicin on nociception and kainic acid-induced behavior in the mouse. Regulatory Peptides. 46: 421-3. PMID 7692555 DOI: 10.1016/0167-0115(93)90107-J  0.38
1993 Kreeger JS, Larson AA. Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice. European Journal of Pharmacology. 238: 111-5. PMID 7691618 DOI: 10.1016/0014-2999(93)90513-H  0.388
1993 Krumins SA, Kim DC, Igwe OJ, Larson AA. DAMGO binding to mouse brain membranes: influence of salts, guanine nucleotides, substance P, and substance P fragments. Peptides. 14: 309-14. PMID 7683401 DOI: 10.1016/0196-9781(93)90046-J  0.356
1993 Larson AA, Sun X. Modulation of kainic acid-induced activity in the mouse spinal cord by the amino terminus of substance P: sensitivity to opioid antagonists. The Journal of Pharmacology and Experimental Therapeutics. 265: 159-65. PMID 7682611  0.355
1993 Skilling SR, Larson AA. Capsaicin inhibits whereas rhizotomy potentiates substance P-induced release of excitatory amino acids in the rat spinal cord in vivo. Neuroscience Letters. 150: 107-11. PMID 7682305 DOI: 10.1016/0304-3940(93)90119-6  0.44
1993 Velázquez RA, Sun X, Kurtz HJ, Larson AA. Possible role of the N-terminus of substance P in kainic acid-induced toxicity in rats. Brain Research. 624: 109-14. PMID 7504568 DOI: 10.1016/0006-8993(93)90066-V  0.421
1992 Budai D, Wilcox GL, Larson AA. Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo. Neuroscience Letters. 135: 265-8. PMID 1625808 DOI: 10.1016/0304-3940(92)90452-D  0.416
1992 Mousseau DD, Sun X, Larson AA. Identification of a novel receptor mediating substance P-induced behavior in the mouse. European Journal of Pharmacology. 217: 197-201. PMID 1385166 DOI: 10.1016/0014-2999(92)90849-Y  0.388
1992 Budai D, Wilcox GL, Larson AA. Modulation of N-methyl-D-aspartate and (R,S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) responses of spinal nociceptive neurons by a N-terminal fragment of substance P. European Journal of Pharmacology. 216: 441-4. PMID 1385165 DOI: 10.1016/0014-2999(92)90443-8  0.431
1992 Skilling SR, Harkness DH, Larson AA. Experimental peripheral neuropathy decreases the dose of substance P required to increase excitatory amino acid release in the CSF of the rat spinal cord. Neuroscience Letters. 139: 92-6. PMID 1383886 DOI: 10.1016/0304-3940(92)90865-5  0.42
1992 Hornfeldt CS, Smullin DH, Schamber CD, Sun X, Larson AA. Antinociceptive effects of intrathecal taurine and calcium in the mouse. Life Sciences. 50: 1925-34. PMID 1375974 DOI: 10.1016/0024-3205(92)90553-2  0.366
1992 Skilling SR, Sun X, Kurtz HJ, Larson AA. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity. Brain Research. 575: 272-8. PMID 1349253 DOI: 10.1016/0006-8993(92)90090-V  0.454
1992 Larson AA, Sun X. Amino terminus of substance P potentiates kainic acid-induced activity in the mouse spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 4905-10. PMID 1281498 DOI: 10.1523/Jneurosci.12-12-04905.1992  0.457
1991 Baker AJ, Zornow MH, Scheller MS, Yaksh TL, Skilling SR, Smullin DH, Larson AA, Kuczenski R. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. Journal of Neurochemistry. 57: 1370-9. PMID 1895110 DOI: 10.1111/J.1471-4159.1991.Tb08303.X  0.316
1991 Magnusson KR, Koerner JF, Larson AA, Smullin DH, Skilling SR, Beitz AJ. NMDA-, kainate- and quisqualate-stimulated release of taurine from electrophysiologically monitored rat hippocampal slices. Brain Research. 549: 1-8. PMID 1893243 DOI: 10.1016/0006-8993(91)90592-J  0.364
1991 Daló NL, Larson AA. Spinal seizures evoked by sudden cooling of amphibian isolated spinal cords: involvement of excitatory amino acids. Cryobiology. 28: 255-67. PMID 1830837 DOI: 10.1016/0011-2240(91)90031-I  0.746
1991 Sun XF, Larson AA. Behavioral sensitization to kainic acid and quisqualic acid in mice: comparison to NMDA and substance P responses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 3111-23. PMID 1719157 DOI: 10.1523/Jneurosci.11-10-03111.1991  0.461
1991 Murray CW, Cowan A, Larson AA. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain. 44: 179-85. PMID 1711193 DOI: 10.1016/0304-3959(91)90135-K  0.442
1991 Jeftinija S, Jeftinija K, Liu F, Skilling SR, Smullin DH, Larson AA. Excitatory amino acids are released from rat primary afferent neurons in vitro. Neuroscience Letters. 125: 191-4. PMID 1679218 DOI: 10.1016/0304-3940(91)90025-O  0.359
1990 Hornfeldt CS, Larson AA. Seizures induced by fluoroacetic acid and fluorocitric acid may involve chelation of divalent cations in the spinal cord. European Journal of Pharmacology. 179: 307-13. PMID 2364992 DOI: 10.1016/0014-2999(90)90170-B  0.357
1990 Igwe OJ, Sun X, Larson AA. Correlation of substance P-induced desensitization with substance P amino terminal metabolites in the mouse spinal cord. Peptides. 11: 817-25. PMID 1700400 DOI: 10.1016/0196-9781(90)90199-F  0.419
1990 Smullin DH, Skilling SR, Larson AA. Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord. Pain. 42: 93-101. PMID 1700356 DOI: 10.1016/0304-3959(90)91095-Z  0.441
1990 Igwe OJ, Kim DC, Seybold VS, Larson AA. Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 3653-63. PMID 1700082 DOI: 10.1523/Jneurosci.10-11-03653.1990  0.369
1990 Daló NL, Larson AA. Effects of urethane and ketamine on substance P- and excitatory amino acid-induced behavior in mice. European Journal of Pharmacology. 184: 173-7. PMID 1698643 DOI: 10.1016/0014-2999(90)90679-Z  0.751
1990 Krumins SA, Kim DC, Larson AA. Substance P modulation of DAMGO binding in the brain of CXBK and Swiss-Webster mice. Peptides. 11: 281-5. PMID 1694028 DOI: 10.1016/0196-9781(90)90083-H  0.352
1990 Skilling SR, Smullin DH, Larson AA. Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 1309-18. PMID 1691775 DOI: 10.1523/Jneurosci.10-04-01309.1990  0.444
1989 Larson AA. Intrathecal GABA, glycine, taurine or beta-alanine elicits dyskinetic movements in mice. Pharmacology, Biochemistry, and Behavior. 32: 505-9. PMID 2727012 DOI: 10.1016/0091-3057(89)90189-5  0.366
1989 Hornfeldt CS, Larson AA. Selective inhibition of excitatory amino acids by divalent cations. A novel means for distinguishing N-methyl-D-aspartic acid-, kainate- and quisqualate-mediated actions in the mouse spinal cord. The Journal of Pharmacology and Experimental Therapeutics. 251: 1064-8. PMID 2574739  0.311
1989 McDonald AJ, Beitz AJ, Larson AA, Kuriyama R, Sellitto C, Madl JE. Co-localization of glutamate and tubulin in putative excitatory neurons of the hippocampus and amygdala: an immunohistochemical study using monoclonal antibodies. Neuroscience. 30: 405-21. PMID 2568603 DOI: 10.1016/0306-4522(89)90261-3  0.311
1989 Larson AA, Igwe OJ, Seybold VS. Effects of lysergic acid diethylamide (LSD) and adjuvant-induced inflammation on desensitization to and metabolism of substance P in the mouse spinal cord. Pain. 37: 365-73. PMID 2474144 DOI: 10.1016/0304-3959(89)90202-9  0.45
1989 Krumins SA, Kim DC, Seybold VS, Larson AA. Modulation of [3H]DAGO binding by substance P (SP) and SP fragments in the mouse brain and spinal cord via MU1 interactions. Neuropeptides. 13: 225-33. PMID 2473408 DOI: 10.1016/0143-4179(89)90075-9  0.381
1988 Magnusson KR, Madl JE, Clements JR, Wu JY, Larson AA, Beitz AJ. Colocalization of taurine- and cysteine sulfinic acid decarboxylase-like immunoreactivity in the cerebellum of the rat with monoclonal antibodies against taurine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 4551-64. PMID 3199192 DOI: 10.1523/Jneurosci.08-12-04551.1988  0.315
1988 Larson AA, Beitz AJ. Glycine potentiates strychnine-induced convulsions: role of NMDA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 3822-6. PMID 2903914 DOI: 10.1523/Jneurosci.08-10-03822.1988  0.427
1988 Miller KE, Clements JR, Larson AA, Beitz AJ. Organization of glutamate-like immunoreactivity in the rat superficial dorsal horn: light and electron microscopic observations. Synapse (New York, N.Y.). 2: 28-36. PMID 2901792 DOI: 10.1002/Syn.890020106  0.368
1988 Skilling SR, Smullin DH, Beitz AJ, Larson AA. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. Journal of Neurochemistry. 51: 127-32. PMID 2898001 DOI: 10.1111/J.1471-4159.1988.Tb04845.X  0.411
1988 Igwe OJ, Felice LJ, Seybold VS, Larson AA. Optimization of high-performance liquid chromatography-radioimmunoassay protocols for the analyses of substance P and some of its metabolic fragments. Journal of Chromatography. 432: 113-26. PMID 2464606 DOI: 10.1016/S0378-4347(00)80638-6  0.353
1988 Larson AA. Desensitization to intrathecal substance P in mice: possible involvement of opioids. Pain. 32: 367-74. PMID 2452400 DOI: 10.1016/0304-3959(88)90049-8  0.399
1987 Clements JR, Madl JE, Johnson RL, Larson AA, Beitz AJ. Localization of glutamate, glutaminase, aspartate and aspartate aminotransferase in the rat midbrain periaqueductal gray. Experimental Brain Research. 67: 594-602. PMID 2888681 DOI: 10.1007/BF00247290  0.359
1986 Larson AA, Dalo NL. Quantification of tryptamine in brain using high-performance liquid chromatography. Journal of Chromatography. 375: 37-47. PMID 3958108 DOI: 10.1016/S0378-4347(00)83689-0  0.699
1986 Larson AA, Anderson EG. Action of hallucinogens on raphe-evoked dorsal root potentials (DRPs) in the cat. Pharmacology, Biochemistry, and Behavior. 24: 347-50. PMID 3952125 DOI: 10.1016/0091-3057(86)90364-3  0.37
1986 Larson AA, Brown DR, el-Atrash S, Walser MM. Pain threshold changes in adjuvant-induced inflammation: a possible model of chronic pain in the mouse. Pharmacology, Biochemistry, and Behavior. 24: 49-53. PMID 3945666 DOI: 10.1016/0091-3057(86)90043-2  0.35
1986 McCormack JK, Beitz AJ, Larson AA. Autoradiographic localization of tryptamine binding sites in the rat and dog central nervous system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 94-101. PMID 3944625 DOI: 10.1523/Jneurosci.06-01-00094.1986  0.319
1986 Magnusson KR, Larson AA, Madl JE, Altschuler RA, Beitz AJ. Co-localization of fixative-modified glutamate and glutaminase in neurons of the spinal trigeminal nucleus of the rat: an immunohistochemical and immunoradiochemical analysis. The Journal of Comparative Neurology. 247: 477-90. PMID 2873153 DOI: 10.1002/Cne.902470407  0.337
1986 Monaghan PL, Beitz AJ, Larson AA, Altschuler RA, Madl JE, Mullett MA. Immunocytochemical localization of glutamate-, glutaminase- and aspartate aminotransferase-like immunoreactivity in the rat deep cerebellar nuclei. Brain Research. 363: 364-70. PMID 2867817 DOI: 10.1016/0006-8993(86)91024-3  0.343
1986 Beitz AJ, Larson AA, Monaghan P, Altschuler RA, Mullett MM, Madl JE. Immunohistochemical localization of glutamate, glutaminase and aspartate aminotransferase in neurons of the pontine nuclei of the rat. Neuroscience. 17: 741-53. PMID 2422596 DOI: 10.1016/0306-4522(86)90042-4  0.345
1986 Jeftinija S, Raspantini C, Randić M, Yaksh TL, Go VL, Larson AA. Altered responsiveness to substance P and 5-hydroxytryptamine in cat dorsal horn neurons after 5-HT depletion with p-chlorophenylalanine. Brain Research. 368: 107-15. PMID 2420413 DOI: 10.1016/0006-8993(86)91047-4  0.309
1986 Madl JE, Larson AA, Beitz AJ. Monoclonal antibody specific for carbodiimide-fixed glutamate: immunocytochemical localization in the rat CNS. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 34: 317-26. PMID 2419390 DOI: 10.1177/34.3.2419390  0.322
1985 Beitz AJ, Larson AA. Inhibition of intrathecally administered picrotoxin- and bicuculline-induced convulsions in mice by pipecolic acid or GABA. European Journal of Pharmacology. 114: 181-7. PMID 2995078 DOI: 10.1016/0014-2999(85)90626-0  0.37
1984 Larson AA. Acute and chronic effects of LSD and 5-MeODMT on raphe-evoked dorsal root potentials in the cat. Life Sciences. 34: 1193-201. PMID 6708724 DOI: 10.1016/0024-3205(84)90092-4  0.371
1984 Larson AA. Interactions between ketamine and phencyclidine and dorsal root potentials (DRPs), evoked from the raphe nuclei. Neuropharmacology. 23: 785-91. PMID 6089025 DOI: 10.1016/0028-3908(84)90112-6  0.364
1983 Larson AA. Hyperalgesia produced by the intrathecal administration of tryptamine to rats. Brain Research. 265: 109-17. PMID 6687825 DOI: 10.1016/0006-8993(83)91339-2  0.403
1982 Larson AA. Nociception is enhanced by the intrathecal injection of 5-methoxy-N,N-dimethyltryptamine in the rat. Neuroscience Letters. 33: 323-8. PMID 7162694 DOI: 10.1016/0304-3940(82)90393-7  0.392
1982 Larson AA. Nociception in mice after chronic stress and chronic narcotic antagonists during maturation. Brain Research. 243: 323-8. PMID 7104743 DOI: 10.1016/0006-8993(82)90256-6  0.34
1982 Larson AA, Kondzielski MH. Serotonin-induced gnawing in rats: comparison with tail pinch-induced gnawing. Pharmacology, Biochemistry, and Behavior. 16: 407-9. PMID 6896237 DOI: 10.1016/0091-3057(82)90443-9  0.385
1980 Larson AA, Vaught JL, Takemori AE. The potentiation of spinal analgesia by leucine enkephalin. European Journal of Pharmacology. 61: 381-3. PMID 6892802 DOI: 10.1016/0014-2999(80)90077-1  0.568
1980 Larson AA, Armstrong MJ. Morphine analgesia after intrathecal administration of a narcotic agonist, chloroxymorphamine and antagonist, chlornaltrexamine. European Journal of Pharmacology. 68: 25-31. PMID 6161013 DOI: 10.1016/0014-2999(80)90056-4  0.402
1978 Larson AA, Takemori AE. Effect of morphine on the fate of newly transported tryptophan and 5-hydroxytryptophan in brain of rats. The Journal of Pharmacology and Experimental Therapeutics. 205: 265-73. PMID 305957  0.461
1977 Larson AA, Takemori AE. Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance. Life Sciences. 21: 1807-11. PMID 604708 DOI: 10.1016/0024-3205(77)90162-X  0.544
1977 Larson AA, Takemori AE. Effect of narcotics on the uptake of serotonin precursors by the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 200: 216-23. PMID 299890  0.481
Show low-probability matches.